There were no major surprises in EssilorLuxottica’s FY21 performance. The sales and EBIT were almost in line with street estimates. Among the positives, the Q4 sales momentum has continued into the new financial year. The profit margin has diluted with the consolidation of GrandVision. However, the target for 2022-26 looks achievable management’s recent success (despite multiple headwinds) adds to our positivity. We will improve the financial estimates but maintain a cautious stance on the stock ....
14 Mar 2022
Well poised to sustain the 2021 momentum!
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Well poised to sustain the 2021 momentum!
There were no major surprises in EssilorLuxottica’s FY21 performance. The sales and EBIT were almost in line with street estimates. Among the positives, the Q4 sales momentum has continued into the new financial year. The profit margin has diluted with the consolidation of GrandVision. However, the target for 2022-26 looks achievable management’s recent success (despite multiple headwinds) adds to our positivity. We will improve the financial estimates but maintain a cautious stance on the stock ....